While endurance running is widely celebrated for its health benefits, a trailblazing study led by Tim Cannon, MD, Sheridan Director of the Molecular Tumor Board and Co-Director of the Gastrointestinal Cancer Program at Inova Schar Cancer, reveals a surprising link to colon cancer risk. Featured in Runner’s World, the research opens important conversations around screening guidelines and reinforces the importance of proactive health monitoring, regardless of one’s fitness level.
Article links:
What is hsCRP, and how can it help predict your risk of developing heart disease?…
Recognition from U.S. News & World Report, Modern Healthcare and Press Ganey highlights Inova's commitment…
Raj Chand, MD, to serve as Interim President, Inova Loudoun Hospital Fairfax, VA — Inova is pleased to announce…
FDA-approved technology helps surgeons visualize ovarian cancer in real time during surgery FAIRFAX, Va. –…
Leesburg, VA — Inova Loudoun Hospital Mobile Health Services will be providing countywide blood pressure…
Study at a glanceInova’s incidental lung nodule program has shown a 76% reduction in time…